C16H25FN2O4S2Sn, monoclinic, P21/n (no. 14), a = 11.2227(1) Å, b = 12.6793(1) Å, c = 13.8731(1) Å, β = 98.282(1)°, V = 1953.50(3) Å3, Z = 4, Rgt(F) = 0.0198, wRref(F2) = 0.0507, T = 100(2) K
C27H34N4O3S2, monoclinic, P21/c (no. 14), a = 17.7267(7) Å, b = 10.5415(5) Å, c = 14.1637(4) Å, β = ...
C8H18ClNS2Sn, triclinic, P1̄ (no. 2), a = 6.4399(2) Å, b = 9.6430(3) Å, c = 11.6944(1) Å, α = 91.966...
The X-ray crystal structure determination of tri-n-butyltin 2,6-difluorobenzoate, compound 4, reveal...
C28H20Cl2F2N2O2Sn, monoclinic, P21/c (no. 14), a = 27.8125(4) Å, b = 8.4443(2) Å, c = 10.7891(1) Å, ...
C84H52Cl8F16O10Sn4, triclinic, P1̄ (no. 2), a = 11.2999(9) Å, b = 14.1471(11) Å, c = 15.2378(12) Å, ...
C52H48N4O10Sn2, triclinic, P1̄ (no. 2), a = 8.4845(1) Å, b = 9.2814(1) Å, c = 15.5517(2) Å, α = 83.0...
C21H18FN3O3S, monoclinic, P 21 (no. 4), a = 11.6665(3) Å, b = 5.7483(2) Å, c = 14.7695(4) Å, α = 90°...
C26H38N2S4Sn, triclinic, P 1 ‾ (no. 2), a = 9.6272(1) Å, b = 12.1043(2) Å, c = 13.3584(2) Å, α = 82....
C54H50Cl4O2P2Sn, triclinic, P1̄ (no. 2), a = 10.6360(2) Å, b = 10.8406(2) Å, c = 12.5727(2) Å, α = 9...
C13H19ClN2S2Sn, triclinic, P1̄ (no. 2), a = 6.5837(2) Å, b = 9.9458(2) Å, c = 12.8720(3) Å, α = 85.3...
C24H22Cl2N2O2Sn, monoclinic, P21/n (no. 14), a = 12.6418(1) Å, b = 13.2422(1) Å, c = 13.6364(1) Å, β...
Crystal structure determinations of {[(F5C6COO)Bu2Sn]2O}2 and {[(4‐F‐C6H4COO)‐Bu2Sn]2O}2 show that t...
C26H26F1N3O3S1, triclinic, P1̅ (no. 2), a = 7.0252(14) Å, b = 9.3017(19) Å, c = 19.388(4) Å, α = 97....
C20H18FNO4S, monoclinic, P12(1)/n1 (no. 14), a = 12.537(1) angstrom, b = 11.902(1) angstrom, c = 12....
C24H27FN2O9S, orthorhombic, P212121 (no. 19), a = 11.2301(12) Å, b = 11.9074(13) Å, c = 20.738(2) Å,...
C27H34N4O3S2, monoclinic, P21/c (no. 14), a = 17.7267(7) Å, b = 10.5415(5) Å, c = 14.1637(4) Å, β = ...
C8H18ClNS2Sn, triclinic, P1̄ (no. 2), a = 6.4399(2) Å, b = 9.6430(3) Å, c = 11.6944(1) Å, α = 91.966...
The X-ray crystal structure determination of tri-n-butyltin 2,6-difluorobenzoate, compound 4, reveal...
C28H20Cl2F2N2O2Sn, monoclinic, P21/c (no. 14), a = 27.8125(4) Å, b = 8.4443(2) Å, c = 10.7891(1) Å, ...
C84H52Cl8F16O10Sn4, triclinic, P1̄ (no. 2), a = 11.2999(9) Å, b = 14.1471(11) Å, c = 15.2378(12) Å, ...
C52H48N4O10Sn2, triclinic, P1̄ (no. 2), a = 8.4845(1) Å, b = 9.2814(1) Å, c = 15.5517(2) Å, α = 83.0...
C21H18FN3O3S, monoclinic, P 21 (no. 4), a = 11.6665(3) Å, b = 5.7483(2) Å, c = 14.7695(4) Å, α = 90°...
C26H38N2S4Sn, triclinic, P 1 ‾ (no. 2), a = 9.6272(1) Å, b = 12.1043(2) Å, c = 13.3584(2) Å, α = 82....
C54H50Cl4O2P2Sn, triclinic, P1̄ (no. 2), a = 10.6360(2) Å, b = 10.8406(2) Å, c = 12.5727(2) Å, α = 9...
C13H19ClN2S2Sn, triclinic, P1̄ (no. 2), a = 6.5837(2) Å, b = 9.9458(2) Å, c = 12.8720(3) Å, α = 85.3...
C24H22Cl2N2O2Sn, monoclinic, P21/n (no. 14), a = 12.6418(1) Å, b = 13.2422(1) Å, c = 13.6364(1) Å, β...
Crystal structure determinations of {[(F5C6COO)Bu2Sn]2O}2 and {[(4‐F‐C6H4COO)‐Bu2Sn]2O}2 show that t...
C26H26F1N3O3S1, triclinic, P1̅ (no. 2), a = 7.0252(14) Å, b = 9.3017(19) Å, c = 19.388(4) Å, α = 97....
C20H18FNO4S, monoclinic, P12(1)/n1 (no. 14), a = 12.537(1) angstrom, b = 11.902(1) angstrom, c = 12....
C24H27FN2O9S, orthorhombic, P212121 (no. 19), a = 11.2301(12) Å, b = 11.9074(13) Å, c = 20.738(2) Å,...
C27H34N4O3S2, monoclinic, P21/c (no. 14), a = 17.7267(7) Å, b = 10.5415(5) Å, c = 14.1637(4) Å, β = ...
C8H18ClNS2Sn, triclinic, P1̄ (no. 2), a = 6.4399(2) Å, b = 9.6430(3) Å, c = 11.6944(1) Å, α = 91.966...
The X-ray crystal structure determination of tri-n-butyltin 2,6-difluorobenzoate, compound 4, reveal...